Pete Pharma announced a partnership with FABRX, the global pioneer in pharmaceutical 3D printing, to introduce this transformative technology to the US compounding pharmacy market.

FABRX has successfully implemented pharmaceutical 3D printing across hospitals, universities, and clinical research centers worldwide. Through this collaboration, Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the United States for the first time.

“Compounding pharmacies have been eager for meaningful innovation that improves efficiency, enhances compliance, and expands their ability to personalize care for patients,” said Dan Siddall, Founder of Pete Pharma. “By combining FABRX’s proven expertise with Pete Pharma’s commercialization strategy, we are making pharmaceutical 3D printing not only possible, but practical and scalable across the U.S. market.”

This initiative will provide compounding pharmacies with tools to streamline workflows, automate traditionally labor-intensive processes, and enable greater personalization of medications in fields such as pediatrics, hormone replacement therapy, metabolic care, and lifestyle therapeutics. In addition, the platform integrates in-line quality control and digital traceability, strengthening both safety and compliance.

A key element of the launch is Pete Pharma’s first-of-its-kind business model, designed to transform how pharmacies access innovation. Built with a “pharmacy-first” approach, the model prioritizes the needs of pharmacies, ensuring success is measured not only by the delivery of technology, but by the value created through improved patient outcomes. The platform is also designed to be scalable for independent pharmacies nationwide, efficient in reducing labor and consumable waste, and forward-looking in addressing regulatory requirements while reshaping the traditional distribution model in compounding.

“This is more than a technology launch; it is the beginning of a new era for compounding pharmacies,” added Siddall. “We are creating a model that makes advanced pharmaceutical technology accessible in a way that works for the realities of the industry.”

Through this partnership, Pete Pharma and FABRX are setting a new standard for innovation in compounding, creating a future where pharmacies operate more efficiently while delivering more effective, personalized therapies for patients.